Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

According to the American Cancer Society, more than 200,000 women will be diagnosed with invasive breast cancer each year and approximately 40,000 will die from the disease. The human leukocyte antigen (HLA) class I samples peptides derived from proteasomal degradation of cellular proteins and prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Weidanz, Jon A., Doll, Krysten L., Mohana-Sundaram, Soumya, Wichner, Timea, Lowe, Devin B., Gimlin, Susanne, Wawro Weidanz, Debra, Magnusson, Robert, Hawkins, Oriana E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MyJove Corporation 2015
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401383/
https://www.ncbi.nlm.nih.gov/pubmed/25867039
http://dx.doi.org/10.3791/52159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401383/
https://www.ncbi.nlm.nih.gov/pubmed/25867039
http://dx.doi.org/10.3791/52159

Ejemplares similares